Abstract
Background
Early embryonic arrest (EEA) leads to repeated cessation of fresh cycles among infertile women undergoing in vitro fertilization (IVF). Whether the levels of some essential trace elements [copper (Cu), zinc (Zn), selenium (Se) and cobalt (Co)] in the bodies of women are related to the risk of EEA warrants study.
Objective
Our study aimed to investigate the associations of peripheral blood levels of Cu, Zn, Se, and Co and their mixtures with the risk of EEA.
Methods
A total of 74 EEA cases (123 IVF cycles) and 157 controls (180 IVF cycles) from the reproductive center of the First Affiliated Hospital of Anhui Medical University in Hefei, China, between June 2017 and March 2020 were included in our study. Demographic and clinical data were collected from electronic medical records. Cu, Zn, Se, and Co levels were measured in blood samples collected on the day of oocyte retrieval when infertile women entered clinical treatment for the first time using an inductively coupled plasma mass spectrometer (ICP−MS). Generalized estimating equation (GEE) models were used to evaluate the associations of four essential trace element concentrations individually with the risk of EEA, and Bayesian kernel machine regression (BKMR) was used to explore the associations between four essential trace element mixtures and the risk of EEA.
Results
Se concentrations of infertile women were significantly lower in the case group compared with the control group. Co levels were significantly higher in the case group compared with the control group. The differences in Cu and Zn concentrations between the two groups were not significant. Based on single-metal models, Co was positively associated with the risk of EEA before and after adjustment for all confounders (odd ratio (OR) = 1.72, 95% confidence interval (CI): 1.18−2.52; OR = 2.27, 95% CI: 1.37−3.77, respectively), and Se was negatively associated with the risk of EEA before adjustment for all confounders (OR = 0.18, 95% CI: 0.07−0.51). BKMR analyses showed that Se was significantly and negatively associated with the risk of EEA when all the other three metals (Cu, Zn, and Co) were fixed at the 25th, 50th, or 75th percentiles, whereas Zn displayed a significant and positive association with the risk of EEA when all the other three metals (Cu, Se and Co) were fixed at the 25th, 50th, or 75th percentiles. Co did not show any effect on the risk of EEA when all the other metals (Cu, Zn, and Se) were fixed at the 25th, 50th, or 75th percentiles. In addition, an increasing trend of the joint effect of four essential trace elements on the risk of EEA was found, although it was not statistically significant.
Conclusion
The levels of essential trace elements (Cu, Zn, Se, and Co) might correlate with the risk of EEA to some extent. The present study might provide a real-world perspective on the relationship between essential trace elements and the risk of EEA when considering them as a single element or as mixtures.
Keywords: combined effects, early embryonic arrest, BKMR models, essential trace element, mixtures
Introduction
Globally, 15% of couples suffer infertility worldwide, which is equivalent to 48.5 million couples. In addition, the prevalence change depends on the geographical region (1). In 2017, in vitro fertilization (IVF) accounted for 99% of all assisted reproductive technologies (ARTs) used in America (2); only 42% of cycles could achieve clinical pregnancies. It is within the best interest of the clinical community to maximize live birth rates from IVF, to prevent the attendant financial costs (3), psychological stress (4), and health concerns (5). Therefore, exploring risk factors affecting the success of ART is of great importance.
Early embryonic arrest (EEA), which is defined as the stagnation of the growth of early embryos cultured in vitro at the four- to eight-cell stage and the cessation of development, is one of the major causes of the recurrent failure of IVF cycles (6). Previous studies have found that four- to eight-cell embryos are in the phase of zygotic gene activation (7), a stage in which some mechanisms are being established and transformed. Some studies found that adverse environmental and genetic factors may lead to embryo stagnation at the four- to eight-cell stage and EEA occurrence, such as chromosomal aneuploidies (8), gene mutations or deletions (9), and maternal obesity (10).
To date, limited studies have been conducted on the relationship between the status of essential trace elements in the human body and IVF outcomes, even though appropriate levels of essential trace elements are seemingly needed for the success of ART (11). For instance, Wu et al. found that seminal Se levels were positively associated with pregnancy and live birth, and female serum Se levels were positively associated with blastocyst development (12). Another study in the USA identified unexpected negative associations between follicular fluid (FF) Zn and the proportion of oocytes fertilized, whereas higher FF Co levels were associated with a lower average embryo cell number per woman (13). Zinc (Zn), selenium (Se), copper (Cu), and cobalt (Co) accomplish decisive functions to maintain human health (12, 13) and play significant roles in human and mammalian reproduction. However, data describing the association of the status of essential trace elements with IVF outcomes, especially EEA, are very limited.
Therefore, in the present study, we aimed to investigate the associations of peripheral blood concentrations of four essential trace elements (Cu, Zn, Se, and Co) and their mixtures with the risk of EEA to provide a real-world perspective on the relationship between essential trace elements and EEA.
Materials and methods
Study design and participants
Couples with infertility were recruited from June 2017 to March 2020 at the Reproduction Centre of the First Affiliated Hospital of Anhui Medical University in Hefei, Anhui Province, China, to participate in this case−control study. The case group was defined based on the following criteria (1): aged between 20 and 40 years (2); EEA occurred in at least one IVF or ICSI treatment cycle; (3) both couples had no reported familial genetic factors and normal chromosomes; (4) the male partner’s sperm was of good quality; and (5) no donor oocytes or sperm were used in the ART process. The control group was matched for age and BMI with the same criteria as the case group, except for embryo quality, who had normal early embryo development and obtained at least 70% high-quality blastocysts in each oocyte retrieval cycle. Finally, 74 cases undergoing 123 cycles and 157 controls undergoing 180 cycles were included in this study. We obtained information about the demographic characteristics, clinical features, and medical history of the participants from the hospital electronic health system.
IVF procedure and outcome assessment
The IVF process occurred as follows. First, women underwent one type of controlled ovarian hyperstimulation (COH) protocol, including long, short, gonadotropin-releasing hormone antagonist or microstimulation protocols, which were based on their ovarian response function and ages. Second, ovulation was triggered with human chorionic gonadotropin (hCG; 10,000 IU) when a minimum of two follicles had matured (diameter ≥18 mm). Third, after 36 h, oocyte retrieval was performed, and fresh semen was collected on the same day. Finally, the oocytes were fertilized by conventional insemination or ICSI based on clinical indications.
The numbers of retrieved mature oocytes (metaphase II, MII), oocytes with two pronuclei, and high-quality embryos was assessed after oocyte retrieval and fertilization. The Gardner system was used to evaluate blastocyst quality. Blastocysts of grade ≥4 BB on Days 5–6 were designated as high-quality blastocysts. To ensure high intra- and interrater reliabilities, we assigned two fixed embryologists to evaluate the quality of each embryo simultaneously.
Sample collection and exposure assessment
Fasting anticoagulant blood samples from infertile women on the day of oocyte retrieval when they started clinical treatment for the first time were stored at −80°C until further assessment. Then, 500 μl HNO3 and a 10 mg/L gold (Au) solution (50 μl) were added to 100 μl of blood after the blood was thawed. The above mixture was digested for at least 1 h at 100°C. The completely digested mixture was diluted 1:50 with 0.05% Triton X-100.
The blood concentrations of Cu, Zn, Se, and Co were determined by ICPMS (Perkin Elmer NexION 350X, Shelton, CT, USA) simultaneously. In brief, 65Cu, 66Zn, 78Se, and 59Co were used as the isotopes; a multiple-element mixture standard stock solution (10 μg/ml, Perkin Elmer, USA, N9300233) and a multiple internal standard mixture solution (10 μg/ml) (Perkin Elmer, USA, N9303832) were used during determination. Multielement standard curves were prepared by serially diluting the standard stock solution. Finally, calibration curve details were as follows: 0.0 μg/L, 10.0 μg/L, 50.0 μg/L, 100.0 μg/L, and 200.0 μg/L for Cu; 0.0 μg/L, 50.0 μg/L, 100 μg/L, 200 μg/L, and 300 μg/L for Zn; 0.0 μg/L, 1.0 μg/L, 2.0 μg/L, 5.0 μg/L, 10.0 μg/L, and 20 μg/L for Se; and 0.0 μg/L, 1.0 μg/L, 2.0 μg/L, 5.0 μg/L, and 10.0 μg/L for Co. The kinetic energy discrimination mode was used for four elements. Sc was used as the internal standard element for the above analytes, and the final concentration of the internal standard was 20.0 μg/L.
The limits of detection (LODs) of Cu, Zn, Se, and Co were 0.136 μg/L, 0.845 μg/L, 0.575 μg/L, and 0.008 μg/L, respectively. The recovery rates of Cu, Zn, Se, and Co were 88.80%, 90.27%, 102.30%, and 105.55%, respectively.
Statistical analyses
We used the mean ± standard deviation (SD), median (P 25-P 75), or percentiles to describe demographic characteristics and clinical indicators, and the chi-square test was used to compare categorical variables. Student’s t test was used to compare continuous variables that conformed to a normal distribution, and the Mann−Whitney U test was used to compare continuous variables that were not normally distributed between the case and control groups.
Generalized estimating equation (GEE) models were used to account for multiple IVF cycles in the same women according to previous studies (14, 15) to evaluate the associations of blood Cu, Zn, Se, and Co levels with the risk of EEA, and a binary distribution with a logit link function was used. In the above GEE models, Cu, Zn, Se, and Co levels were considered as continuous variables. Some covariates retained in the GEE models were selected based on the following criteria: reportedly related with the outcome or levels of Cu, Zn, Se, and Co or covariates that induced a >10% change in the main effect estimate in the unadjusted model. Finally, the following covariates were included in the adjusted models: cycle, age, BMI, education, duration of infertility, infertility diagnosis, passive smoking, and number of cycles. Active smoking and alcohol consumption before pregnancy were not included in the models because few infertile women reported smoking and drinking.
Because Cu, Zn, Se, and Co were highly correlated with each other and the relationship between these levels and EEA might not be linear, Bayesian kernel machine regression (BKMR) was used to flexibly model the joint effect of the mixture of Cu, Zn, Se, and Co levels on EEA and isolate single metal risk differences. BKMR could not only allow us to estimate nonlinear and nonadditive dose−response functions for a group of correlated metal exposures but also identify the contribution of every individual factor to the mixture effect; additionally, the form of the exposure–response function does not require a priori specification (16). In our present study, we modeled the exposure–response function as a weighted sum of Gaussian kernels. The following equation was employed: Yi = h{Cu, Zn, Se, Co} + βq Zi + ei. Specifically, h{} was the exposure–response function of different exposure levels (Cu, Zn, Se, Co). The coefficient βq was the effect estimates of the covariates. Zi represented potential confounding factors that needed to be adjusted for, and ei represented residuals. The model was run for up to 10,000 iterations. The combined effect of Cu, Zn, Se, and Co was estimated with all four metals at a specified threshold (25th, 30th, 35th,…, 75th percentile) compared to when the four metals were all set at the 50th percentile. The single effect of four metals was estimated by changing the levels of one metal from its 25th percentile to the 75th percentile while keeping the other three metals at their 25th, 50th, or 75th percentile. The univariate exposure–response function was employed when one metal was regarded as an independent continuous variable and EEA was regarded as a dependent binary outcome, while the other three metals were set at their medians. Finally, in the BKMR model, hierarchical variable selection was conducted to identify the metal with the greatest contribution within the mixture and displayed as the posterior inclusion probability (PIP).
All data were analyzed using SPSS for Windows (version 22.0; SPSS UK Ltd., Surrey, UK) or R (version 4.0.5, package ‘‘bkmr’’ and ‘‘ggplot2’’), and a two-sided p value <0.05 was considered statistically significant for all the tests unless otherwise indicated.
Results
Demographic and clinical characteristics
The demographic characteristics of 231 participants are shown in Table 1 . The mean ± SD ages of women in the case and control groups were 33.28 ± 4.93 years and 32.04 ± 3.70 years, respectively, and the body mass index (BMI, calculated as body mass (kg) divided by height squared (m2), normal range: 18.5−24.9 kg/m2) was 22.43 ± 3.57 kg/m2 and 22.17 ± 3.12 kg/m2, respectively. Greater than 50% of women in both groups had higher education (college or above); 39.2% of cases and 42.7% of controls were exposed to secondhand smoke. The differences in the above characteristics were not significant between the two groups. In addition, other than diagnoses regarding causes of infertility, no significant differences were observed between the women of both groups with respect to women’s ages at menarche, their husbands’ ages, and sperm quality indices. With regard to levels of essential trace elements, the levels of Se of infertile women in the case group were lower than those in the control group (p = 0.034). No differences in Cu, Co, and Zn levels were noted between groups.
Table 1.
Characteristics | Cases | Controls | p-Value |
---|---|---|---|
Maternal age (y) | 33.28 ± 4.93 | 32.04 ± 3.70 | 0.056 |
Maternal BMI a (kg/m2) | 0.424 | ||
Underweight | 7 (9.6) | 11 (7.1) | |
Normal | 46 (63.0) | 112 (72.3) | |
Overweight | 17 (23.3) | 24 (15.5) | |
Obesity | 3 (4.1) | 8 (5.2) | |
Education | 0.991 | ||
High school or below | 40 (54.1) | 84 (53.5) | |
College | 31 (41.9) | 67 (42.7) | |
University or above | 3 (4.1) | 6 (3.8) | |
Duration of infertility (y) | 0.846 | ||
< 5 | 58 (78.4) | 128 (81.5) | |
5 - 10 | 14 (18.9) | 25 (15.9) | |
> 10 | 2 (2.7) | 4 (2.5) | |
Passive smoking | 0.669 | ||
No | 45 (60.8) | 90 (57.3) | |
Yes | 29 (39.2) | 67 (42.7) | |
Age at menarche (y) | 0.561 | ||
≤12 | 8 (10.8) | 12 (7.6) | |
13–14 | 51 (68.9) | 106 (67.5) | |
15–16 | 14 (18.9) | 32 (20.4) | |
≥17 | 1 (1.4) | 7 (4.5) | |
Infertility diagnosis | <0.001 | ||
Pelvic adhesion, oviductal obstruction, etc. b | 51 (68.9) | 152 (96.8) | |
DOR | 11 (14.9) | 2 (1.3) | |
PCOS & EMT | 10 (13.5) | 2 (1.3) | |
RSA | 2 (2.7) | 1 (0.6) | |
Paternal age | 34.18 ± 5.83 | 32.90 ± 4.87 | 0.083 |
Paternal sperm concentration (× 106) c | 40.55 (23.60, 82.83) | 54.60( 32.15, 99.75) | 0.053 |
Paternal sperm motility (%) d | 36.10 (22.40, 54.40) | 42.10 (29.58, 55.85) | 0.075 |
Paternal sperm viability (%) e | 59.65 (43.93, 78.10) | 68.60 (52.68, 79.75) | 0.181 |
Essential trace element concentration | |||
Cu (μg/L) | 587.79 (540.75, 663.49) | 572.73 (529.44, 653.35) | 0.468 |
Zn (μg/L) | 7231.98 (5981.56, 7854.43) | 6715.91 (5601.17, 7645.23) | 0.095 |
Se (μg/L) | 93.54 (75.78, 105.07) | 98.69 (83.80, 112.21) | 0.034 |
Co (μg/L ) | 0.28 (0.19, 0.46) | 0.25 (0.19, 0.36) | 0.152 |
BMI, body mass index; DOR, diminished ovarian reserve; PCOS & EMT, polycystic ovarian syndrome & endometriosis; RSA, recurrent abortion;
In the case group, one participant whose information about BMI was missing; in the control group, two participants whose information about BMI were missing;
Pelvic adhesion, oviductal obstruction, etc. included the sequelae of pelvic inflammatory disease, scar uterus, chronic salpingitis, salpingectomy after ectopic pregnancy, unilateral tubal obstruction, and bilateral tubal obstruction;
In the case group, six participants whose information about paternal sperm concentration were missing; in the control group, eight participants whose information about paternal sperm concentration were missing;
In the case group, 26 participants whose information about paternal sperm viability were missing; in the control group, 35 participants whose information about paternal sperm viability were missing;
In the case group, 11 participants whose information about paternal sperm motility were missing; in the controls group, 23 participants whose information about paternal sperm motility were missing.
The mean number of IVF cycles per woman was 1.7 in the case group (74 women with 123 cycles) and 1.1 in the control group (157 women with 180 cycles), as presented in Table S1 . Therefore, the number of total cycles was 303 for all infertile women in the study. The clinical characteristics and cycle outcomes of the 231 participants (303 cycles) are shown in Table S2 . All the clinical characteristics and cycle outcomes, including treatment protocol, COH outcomes, oocyte insemination technique, and in vitro fertilization outcomes, in the case group were significantly different from those in the control group.
We treated natural logarithm transformed levels of Cu, Zn, Se, and Co as continuous variables and fitted GEE models to assess the single effect of every element on the risk of EEA. A significantly positive association between Co concentration and EEA risk was found in both the unadjusted and adjusted models (OR = 1.72; 95% CI: 1.18−2.52 and OR = 2.27; 95% CI: 1.37−3.77, respectively). A significantly negative association between Se concentration and the risk of EEA was found in the unadjusted model (OR = 0.18; 95% CI 0.07−0.51); however, the significant association disappeared after adjusting for some confounders (OR = 0.32; 95% CI: 0.07−1.34). No significant association was noted between Cu or Zn and the risk of EEA. The results are presented in Table 2 .
Table 2.
Metals | Model 1 a | Model 2 b | ||
---|---|---|---|---|
OR (95% CI) | p-value | OR (95% CI) | p-value | |
lnCu | 1.18 (0.42, 3.33) | 0.631 | 1.67 (0.46, 6.07) | 0.433 |
lnZn | 1.43 (0.50, 4.08) | 0.503 | 3.36 (0.59, 19.14) | 0.173 |
lnSe | 0.18 (0.07, 0.51) | 0.001 | 0.32 (0.07, 1.34) | 0.118 |
lnCo | 1.72 (1.18, 2.52) | 0.005 | 2.27 (1.37, 3.77) | 0.001 |
OR, odds ratio; CI, confidence interval; Cu, copper; Zn, zinc; Se, Selenium; Co, cobalt; ln, natural logarithm transformed.
covariates included number of cycles.
covariates included age, BMI, education, duration of infertility, infertility diagnosis, passive smoking and number of cycles.
Spearman correlation analyses showed that the natural logarithm transformed levels of Cu, Zn, Se, and Co were highly correlated with each other ( Table 3 ). Considering that these elements exist simultaneously in the human body, the BKMR model was used to assess the joint effect of the four-element mixture on the risk of EEA. Figure 1 shows the results of the covariate-adjusted BKMR analyses for the risk of EEA. Figure 1A represents the overall effects of the four-element mixture, showing the estimated differences in odds ratios of EEA and 95% CIs when all element concentrations were held at a certain percentile compared to when all elements were held at their median concentrations. We did not observe an overall effect of the four-element mixture on the risk of EEA. Single-element risk differences of changing the concentration of a single element from the observed 25th percentile to the 75th percentile while holding other metals at their 25th, 50th, or 75th percentiles were also estimated. We found that only the 95% CI for the ORs of Se and Zn did not cross 0, and the risk of EEA decreased with increasing Se concentrations, whereas the risk of EEA increased with increasing Zn ( Figure 1B ). Based upon the estimated PIPs, BKMR identified Se (0.9506) as the most important contributor to the overall association followed by Zn, Co, and Cu ( Table 4 ). Figure 1C shows the univariate exposure−response relationship and 95% CIs for one element and the risk of EEA based upon the estimated kernel function, controlling for the other three elements by holding them at their median concentrations. We found that the blood level of Se was negatively associated with the risk of early embryonic arrest, whereas Cu, Zn, and Co levels were positively related to the risk of early embryonic arrest.
Table 3.
Metals | lnCu | lnZn | lnSe | lnCo |
---|---|---|---|---|
lnCu | 1 | -0.28** | 0.07 | 0.26** |
lnZn | 1 | 0.55** | -0.19* | |
lnSe | 1 | -0.17* | ||
lnCo | 1 |
*indicates p value < 0.05; ** indicates p value < 0.001 Table 4 .
Table 4.
Metal | PIP |
---|---|
Cu | 0.6712 |
Zn | 0.8788 |
Se | 0.9506 |
Co | 0.7708 |
Discussion
The results of this exploratory study indicated that the levels of essential trace elements (Cu, Zn, Se, and Co) might correlate with the risk of EEA to some extent. Although Co is an important constituent of vitamin B12 (17), higher Co levels in the human body can still lead to damage to various organs and tissues, such as the liver, kidney, pancreas, and heart, possibly through the generation of reactive oxygen species (ROS) and/or disturbance of DNA repair processes (17–21). To date, epidemiological studies on the association between Co levels in the human body and reproductive outcomes are very limited. In our study, the blood Co levels of women in the case group were not significantly higher than those in the control group. Additionally, we found that blood Co levels were positively associated with the risk of EEA only in the single-metal model, and the positive association no longer existed when all the other three metals (Cu, Zn, and Se) were fixed at the 25th, 50th, or 75th percentiles. Because blood Se level was negatively associated with the risk of EEA in infertile Chinese women in both the single-metal and BKMR models, the results implied that the harmful effect of Co on the risk of early embryonic development might be antagonized by the protective effect of Se.
A double-blind randomized intervention study including 120 female patients undergoing assisted reproductive techniques indicated that oral Se supplementation was significant in terms of obtaining good-quality embryos (22). Despite no statistically significant difference between the Se level and the risk of EEA in the adjusted single-metal model, our findings still showed that Se blood levels were negatively associated with the risk of EEA in Chinese infertile women, and the result was robust in the BKMR model. These findings implied that Se was beneficial for embryonic development. Additionally, women were always exposed to trace element mixtures rather than only one type of element. Element mixtures may have reciprocal effects on the risk of EEA, and Se was the most important element in the BKMR model. The results of the BKMR model were clearly more convincing. The beneficial effect of Se on reproduction might be because Se is a cofactor of antioxidative enzymes. These enzymes are responsible for the neutralization, elimination, and prevention of the synthesis of reactive oxygen species (ROS) (23, 24), and ROS could adversely affect the quality of female oocytes (25).
At present, there are few studies about the relationship between blood copper levels and human early embryonic development. Using a model of rat embryos in vitro, Jankovsky et al. demonstrated that copper is essential for early embryonic development (26). The results from a meta-analysis by Levandovska et al. showed that a decrease in serum copper levels at the beginning of pregnancy was associated with an increased risk of gestational hypertension (27). Prohaska and Brokate found that a specific amount of copper in the body had a protective effect during pregnancy (28). Excessive copper is harmful but rare given that it can lead to the formation of free radicals and destroy cell membranes and proteins in the body (29). Our study revealed no significant differences in blood copper levels between the two groups, which might explain why blood Cu levels were not associated with the risk of early embryonic arrest.
Zn is a cofactor of more than 3000 enzymes that regulate various cellular processes and cellular signaling; it is responsible for the DNA-binding ability of many transcription factors via the unique ability to form molecules known as Zn finger (Znf) proteins. Moreover, Zn is essential for cell division, differentiation, and the development of organs, such as the heart and kidney (30). Surprisingly, the results from our present study showed that when Cu, Se, and Co were fixed at the 25th, 50th, or 75th percentiles using BKMR models, Zn blood levels were positively correlated with the risk of EEA. Although the joint effect of these four elements on EEA was not significant, it still implies that infertile women should maintain appropriate levels of Cu, Zn, Se, and Co to avoid EEA.
To the best of our knowledge, this is the first study to explore the correlation between the risk of early embryonic arrest and Cu, Zn, Se, and Co blood levels in infertile women undergoing IVF in China. In addition, we investigated the associations using the single-element models and the BKMR model to select which element played a leading role. The results from both models showed that Se blood levels were negatively associated with the risk of early embryonic arrest in infertile Chinese women. This finding has important significance for the clinical prevention of early embryonic arrest among infertile women undergoing IVF. Finally, the majority of infertile women in the present study underwent at least one oocyte retrieval cycle; thus, selection bias was effectively avoided.
However, our study still has several limitations that should be interpreted carefully. One potential limitation is that the number of enrolled participants was relatively small, and the findings may be more convincing if a larger sample size was conducted. Another potential limitation is that the biological samples we used to measure the levels of Cu, Zn, Se, and Co were peripheral blood. In contrast, clinical laboratory protocols generally recommend analyzing serum Cu, Zn, Se, and Co levels to assess essential trace element status, including deficiency and overload conditions (31). However, some previous studies also used blood as a biological sample to assess the status of some essential trace elements in the human body (32, 33). Moreover, as a microenvironment composed of a serum ultrafiltrate, follicular fluid is in direct contact with a developing oocyte and its surrounding somatic cells (34, 35). Compared with blood, follicular fluid better reflects the internal environmental state (36). Another limitation of our study is that we measured the levels of these four elements at a single time point: on the day of oocyte retrieval when women initially began clinical treatment. However, our ability to assess the average cumulative status of these trace elements was limited in those patients who have undergone two or more oocyte retrieval cycles. Finally, this was a case−control study that could not infer a causal relationship between essential trace element status and the risk of EEA.
Conclusion
We found that the levels of essential trace elements (Cu, Zn, Se, and Co) might correlate with the risk of EEA to some extent. The present study might provide a real-world perspective of the relationship between essential trace elements and the risk of EEA when considering them as a single element or as mixtures.
Data availability statement
The original contributions presented in the study are included in the article/ Supplementary Material . Further inquiries can be directed to the corresponding authors.
Ethics statement
The studies involving human participants were reviewed and approved by The Biomedical Ethics Committee of Anhui Medical University. The patients/participants provided their written informed consent to participate in this study.
Author contributions
YC, CL, and LS performed the study, analyzed the data, and drafted the manuscript. ZZ, TJ, DYL, and WZ contributed to the study conception. KZ and DL supervised the study. DJ, and YXC critically revised the manuscript and approved the final draft. All authors read and approved the final version of the manuscript.
Funding
This work was supported by the National Natural Science Foundation of China (NSFC-U20A20350, NSFC-82173532, NSFC-81971455, NSFC-81871216, and NSFC-81601345), Postdoctoral Research Foundation of China (2021M700181), and Excellent Young Talents Fund Program of Higher Education Institutions of Anhui Province (gxyq2021173).
Acknowledgments
The authors are grateful to the Scientific Research Center in Preventive Medicine, School of Public Health, Anhui Medical University for the technical support in our experiment. We are also very grateful to Yajing Liu for helping us.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Supplementary material
The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fendo.2022.906849/full#supplementary-material
References
- 1. Agarwal A, Mulgund A, Hamada A, Chyatte MR. A unique view on Male infertility around the globe. Reprod Biol Endocrinol: RB&E (2015) 13:37. doi: 10.1186/s12958-015-0032-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2. Sunderam S, Kissin DM, Zhang Y, Jewett A, Boulet SL, Warner L, et al. Assisted reproductive technology surveillance - United States, 2017. MMWR Surveill Summ (2020) 69(9):1–20. doi: 10.15585/mmwr.ss6909a1 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3. Katz P, Showstack J, Smith JF, Nachtigall RD, Millstein SG, Wing H, et al. Costs of infertility treatment: Results from an 18-month prospective cohort study. Fertil Steril (2011) 95(3):915–21. doi: 10.1016/j.fertnstert.2010.11.026 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4. Cassidy T, Sintrovani P. Motives for parenthood, psychosocial factors and health in women undergoing ivf. J Reprod Infant Psychol (2008) 26(1):4–17. doi: 10.1080/02646830701691392 [DOI] [Google Scholar]
- 5. Zhao J, Li Y, Zhang Q, Wang Y. Does ovarian stimulation for ivf increase gynaecological cancer risk? a systematic review and meta-analysis. Reprod Biomed Online (2015) 31(1):20–9. doi: 10.1016/j.rbmo.2015.03.008 [DOI] [PubMed] [Google Scholar]
- 6. Memili E, First NL. Zygotic and embryonic gene expression in cow: A review of timing and mechanisms of early gene expression as compared with other species. Zygote (2000) 8(1):87–96. doi: 10.1017/s0967199400000861 [DOI] [PubMed] [Google Scholar]
- 7. Asgari V, Hosseini SM, Forouzanfar M, Hajian M, Nasr-Esfahani MH. Vitrification of in vitro produced bovine embryos: Effect of embryonic block and developmental kinetics. Cryobiology (2012) 65(3):278–83. doi: 10.1016/j.cryobiol.2012.08.002 [DOI] [PubMed] [Google Scholar]
- 8. Maurer M, Ebner T, Puchner M, Mayer RB, Duba HC. Chromosomal aneuploidies and early embryonic developmental arrest. Int J Fertility Sterility (2015) 9(3):346–53. doi: 10.22074/ijfs.2015.4550 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9. Wang W, Wang W, Xu Y, Shi J, Fu J, Chen B, et al. Fbxo43 variants in patients with female infertility characterized by early embryonic arrest. Hum Reprod (2021) 36(8):2392–402.doi: 10.1093/humrep/deab131 [DOI] [PubMed] [Google Scholar]
- 10. Han L, Chao R, Ling L, Li X, Ge J, Wang H, et al. Embryonic defects induced by maternal obesity in mice derive from Stella insufficiency in oocytes. Nat Genet (2018) 50(3):432–42. doi: 10.1038/s41588-018-0055-6 [DOI] [PubMed] [Google Scholar]
- 11. Heizer WD. Clinical nutrition of the essential trace elements and minerals. In: Bogden JD, Klevay LM, editors. The guide for health professionals. Totowa, New Jersey: Humana Press; (2000). 3–9 p. [Google Scholar]
- 12. Wu S, Wang M, Deng Y, Qiu J, Zhang X, Tan J. Associations of toxic and essential trace elements in serum, follicular fluid, and seminal plasma with In vitro fertilization outcomes. Ecotoxicol Environ Saf. (2020) 204:110965. doi: 10.1016/j.ecoenv.2020.110965 [DOI] [PubMed] [Google Scholar]
- 13. Komarova T, McKeating D, Perkins AV, Tinggi U. Trace element analysis in whole blood and plasma for reference levels in a selected Queensland population, Australia. Int J Environ Res Public Health (2021) 18(5):2652. doi: 10.3390/ijerph18052652 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14. Banerjee R, Ragsdale SW. The many faces of vitamin B12: Catalysis by cobalamin-dependent enzymes 1. Annu Rev Biochem (2003) 72:209–47. doi: 10.1146/annurev.biochem.72.121801.161828 [DOI] [PubMed] [Google Scholar]
- 15. Carignan CC, Minguez-Alarcon L, Butt CM, Williams PL, Meeker JD, Stapleton HM, et al. Urinary concentrations of organophosphate flame retardant metabolites and pregnancy outcomes among women undergoing in vitro fertilization. Environ Health Perspect (2017) 125(11):119001. doi: 10.1289/EHP1021 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16. Hu P, Vinturache A, Li H, Tian Y, Ding G. Urinary organophosphate metabolite concentrations and pregnancy outcomes among women conceiving through in vitro fertilization in shanghai, China. Environ Health Perspect (2020) 128(9):97007. doi: 10.1289/EHP7076 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17. Bobb JF, Valeri L, Henn BC, Christiani DC, Coull BA. Bayesian Kernel machine regression for estimating the health effects of multi-pollutant mixtures. Biostatistics (2014) 16(3):493. doi: 10.1093/biostatistics/kxu058 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18. Barceloux DG, Barceloux D. Cobalt: Journal of toxicology: Clinical toxicology: Vol 37, no 2. J Toxicol: Clin Toxicol (1999) 37(2):201–16. doi: 10.1081/clt-100102420 [DOI] [PubMed] [Google Scholar]
- 19. Lauwerys R, Lison D. Health risks associated with cobalt exposure–an overview. Sci Total Environ (1994) 150(1-3):1. doi: 10.1016/0048-9697(94)90125-2 [DOI] [PubMed] [Google Scholar]
- 20. Sauni R, Linna A, Oksa P, Nordman H, Tuppurainen M, Uitti J. Cobalt asthma–a case series from a cobalt plant. Occup Med (Lond) (2010) 60(4):301–6. doi: 10.1093/occmed/kqq023 [DOI] [PubMed] [Google Scholar]
- 21. Maxwell P, Salnikow K. Hif-1: An oxygen and metal responsive transcription factor. Cancer Biol Ther (2004) 3(1):29–35. doi: 10.4161/cbt.3.1.547 [DOI] [PubMed] [Google Scholar]
- 22. Petit A, Mwale F, Tkaczyk C, Antoniou J, Zukor DJ, Huk OL. Induction of protein oxidation by cobalt and chromium ions in human U937 macrophages. Biomaterials (2005) 26(21):4416–22. doi: 10.1016/j.biomaterials.2004.11.019 [DOI] [PubMed] [Google Scholar]
- 23. Jiménez Tuñón JM, Trilles PP, Molina MG, Duvison MH, Pastor BM, Martín PS, et al. A double-blind, randomized prospective study to evaluate the efficacy of previous therapy with melatonin, myo-inositol, folic acid, and selenium in improving the results of an assisted reproductive treatment. Clin Med Insights: Ther (2017) 9:1–6. doi: 10.1177/1179559x17742902 [DOI] [Google Scholar]
- 24. Kiełczykowska M, Kocot J, Paździor M, Musik I. Selenium - a fascinating antioxidant of protective properties. Adv Clin Exp Med (2018) 27(2):245–55. doi: 10.17219/acem/67222 [DOI] [PubMed] [Google Scholar]
- 25. Burk RF. Selenium, an antioxidant nutrient. Nutr Clin Care (2002) 5(2):75–9. doi: 10.1046/j.1523-5408.2002.00006.x [DOI] [PubMed] [Google Scholar]
- 26. Prasad S, Tiwari M, Pandey AN, Shrivastav TG, Chaube SK. Impact of stress on oocyte quality and reproductive outcome. J BioMed Sci (2016) 23:36. doi: 10.1186/s12929-016-0253-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27. Jankowski MA, Uriu-Hare JY, Rucker RB, Rogers JM, Keen CL. Maternal zinc deficiency, but not copper deficiency or diabetes, results in increased embryonic cell death in the rat: Implications for mechanisms underlying abnormal development. Teratology (1995) 51(2):85–93. doi: 10.1002/tera.1420510207 [DOI] [PubMed] [Google Scholar]
- 28. Lewandowska M, Sajdak S, Marciniak W, Lubiński J. First trimester serum copper or zinc levels, and risk of pregnancy-induced hypertension. Nutrients (2019) 11(10):2479. doi: 10.3390/nu11102479 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29. Prohaska JR, Brokate B. The timing of perinatal copper deficiency in mice influences offspring survival. J Nutr (2002) 132(10):3142–5. doi: 10.1093/jn/131.10.3142 [DOI] [PubMed] [Google Scholar]
- 30. Scheiber I, Dringen R, Mercer JF. Copper: effects of deficiency and overload. Met Ions Life Sci (2013) 13:359–87. doi: 10.1007/978-94-007-7500-8_11 [DOI] [PubMed] [Google Scholar]
- 31. Kogan S, Sood A, Garnick MS. Zinc and wound healing: A review of zinc physiology and clinical applications. Wounds. (2017) 29(4):102–6. [PubMed] [Google Scholar]
- 32. Ingle ME, Bloom MS, Parsons PJ, Steuerwald AJ, Kruger P, Fujimoto VY. Associations between ivf outcomes and essential trace elements measured in follicular fluid and urine: A pilot study. J Assist Reprod Genet (2017) 34(2):253–61. doi: 10.1007/s10815-016-0853-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33. Bocca B, Ruggieri F, Pino A, Rovira J, Calamandrei G, Mirabella F, et al. Human biomonitoring to evaluate exposure to toxic and essential trace elements during pregnancy. part a. concentrations in maternal blood, urine and cord blood. Environ Res (2019) 177:108599. doi: 10.1016/j.envres.2019.108599 [DOI] [PubMed] [Google Scholar]
- 34. Squadrone S, Brizio P, Abete MC, Brusco A. Trace elements profile in the blood of huntington' disease patients. J Trace Elem Med Biol (2020) 57:18–20. doi: 10.1016/j.jtemb.2019.09.006 [DOI] [PubMed] [Google Scholar]
- 35. Oktem O, Urman B. Understanding follicle growth in vivo. Hum Reprod (2010) 25(12):2944–54. doi: 10.1093/humrep/deq275 [DOI] [PubMed] [Google Scholar]
- 36. Bloom MS, Parsons PJ, Steuerwald AJ, Schisterman EF, Browne RW, Kim K, et al. Toxic trace metals and human oocytes during in vitro fertilization (Ivf). Reprod Toxicol (2010) 29(3):298–305. doi: 10.1016/j.reprotox.2010.01.003 [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
The original contributions presented in the study are included in the article/ Supplementary Material . Further inquiries can be directed to the corresponding authors.